Gilead Sciences IncNASDAQ:GILD
- LAST PRICE88.4000
- TODAY'S CHANGE (%)-3.7100 (-4.0278%)
- Bid / Lots88.4000/ 4
- Ask / Lots88.6000/ 1
- Open / Previous Close91.7100 / 92.1100
- Day Range
- 52 Week Range
- Volume11,454,518
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GILD |
|---|---|---|
| 09:32 ET | 363894 | 91.37 |
| 09:33 ET | 21654 | 91.39 |
| 09:35 ET | 48110 | 91.65 |
| 09:37 ET | 26663 | 91.435 |
| 09:39 ET | 74817 | 90.905 |
| 09:42 ET | 76949 | 90.81 |
| 09:44 ET | 74203 | 90.59 |
| 09:46 ET | 34770 | 90.3 |
| 09:48 ET | 35954 | 90.44 |
| 09:50 ET | 49599 | 90.32 |
| 09:51 ET | 45441 | 90.595 |
| 09:53 ET | 22475 | 90.635 |
| 09:55 ET | 35245 | 90.72 |
| 09:57 ET | 33724 | 90.79 |
| 10:00 ET | 36751 | 90.73 |
| 10:02 ET | 65466 | 90.62 |
| 10:04 ET | 30941 | 90.51 |
| 10:06 ET | 134281 | 90.28 |
| 10:08 ET | 62259 | 90.27 |
| 10:09 ET | 60070 | 89.84 |
| 10:11 ET | 37476 | 89.85 |
| 10:13 ET | 45989 | 89.71 |
| 10:15 ET | 54576 | 89.812497 |
| 10:18 ET | 38622 | 89.72 |
| 10:20 ET | 24081 | 89.75 |
| 10:22 ET | 21266 | 89.69 |
| 10:24 ET | 15462 | 89.77 |
| 10:26 ET | 15028 | 89.74 |
| 10:27 ET | 19407 | 89.68 |
| 10:29 ET | 20513 | 89.66 |
| 10:31 ET | 45185 | 89.68 |
| 10:33 ET | 33534 | 89.59 |
| 10:36 ET | 42261 | 89.624108 |
| 10:38 ET | 31520 | 89.64 |
| 10:40 ET | 31333 | 89.63 |
| 10:42 ET | 67329 | 89.43 |
| 10:44 ET | 40454 | 89.58 |
| 10:45 ET | 34883 | 89.5 |
| 10:47 ET | 27886 | 89.48 |
| 10:49 ET | 20321 | 89.58 |
| 10:51 ET | 27553 | 89.51 |
| 10:54 ET | 23267 | 89.475 |
| 10:56 ET | 21445 | 89.36 |
| 10:58 ET | 36341 | 89.45 |
| 11:00 ET | 12627 | 89.46 |
| 11:02 ET | 17641 | 89.34 |
| 11:03 ET | 18171 | 89.345 |
| 11:05 ET | 9381 | 89.315 |
| 11:07 ET | 10290 | 89.4 |
| 11:09 ET | 16237 | 89.4 |
| 11:12 ET | 12270 | 89.465 |
| 11:14 ET | 11768 | 89.46 |
| 11:16 ET | 16233 | 89.76 |
| 11:18 ET | 50529 | 89.99 |
| 11:20 ET | 21299 | 89.975 |
| 11:21 ET | 11338 | 89.945 |
| 11:23 ET | 18800 | 90.11 |
| 11:25 ET | 20310 | 90.11 |
| 11:27 ET | 40406 | 90.3 |
| 11:30 ET | 13348 | 90.23 |
| 11:32 ET | 17978 | 90.26 |
| 11:34 ET | 14527 | 90.07 |
| 11:36 ET | 38351 | 89.97 |
| 11:38 ET | 12363 | 89.85 |
| 11:39 ET | 13813 | 89.785 |
| 11:41 ET | 9118 | 89.69 |
| 11:43 ET | 18305 | 89.525 |
| 11:45 ET | 19749 | 89.42 |
| 11:48 ET | 26144 | 89.345 |
| 11:50 ET | 27707 | 89.34 |
| 11:52 ET | 15461 | 89.2201 |
| 11:54 ET | 22659 | 89.22 |
| 11:56 ET | 25697 | 89.21 |
| 11:57 ET | 60022 | 89.29 |
| 11:59 ET | 34319 | 89.45 |
| 12:01 ET | 13750 | 89.48 |
| 12:03 ET | 13356 | 89.51 |
| 12:06 ET | 16860 | 89.54 |
| 12:08 ET | 8864 | 89.65 |
| 12:10 ET | 12861 | 89.625 |
| 12:12 ET | 19728 | 89.58 |
| 12:14 ET | 7912 | 89.51 |
| 12:15 ET | 10582 | 89.51 |
| 12:17 ET | 9666 | 89.48 |
| 12:19 ET | 6630 | 89.56 |
| 12:21 ET | 8644 | 89.525 |
| 12:24 ET | 8411 | 89.49 |
| 12:26 ET | 10290 | 89.47 |
| 12:28 ET | 13005 | 89.38 |
| 12:30 ET | 13461 | 89.39 |
| 12:32 ET | 16753 | 89.285 |
| 12:33 ET | 18960 | 89.19 |
| 12:35 ET | 19500 | 89.225 |
| 12:37 ET | 7804 | 89.14 |
| 12:39 ET | 19108 | 89.14 |
| 12:42 ET | 16321 | 89.125 |
| 12:44 ET | 12041 | 89.11 |
| 12:46 ET | 26239 | 89.0909 |
| 12:48 ET | 12889 | 89.13 |
| 12:50 ET | 22027 | 89.13 |
| 12:51 ET | 32095 | 89.11 |
| 12:53 ET | 11250 | 89.115 |
| 12:55 ET | 19598 | 89.07 |
| 12:57 ET | 12730 | 89.15 |
| 01:00 ET | 16591 | 89.1401 |
| 01:02 ET | 19651 | 89.19 |
| 01:04 ET | 50725 | 89.31 |
| 01:06 ET | 10840 | 89.3 |
| 01:08 ET | 14904 | 89.3 |
| 01:09 ET | 9559 | 89.3099 |
| 01:11 ET | 10792 | 89.31 |
| 01:13 ET | 9585 | 89.27 |
| 01:15 ET | 10079 | 89.38 |
| 01:18 ET | 12385 | 89.42 |
| 01:20 ET | 7922 | 89.3576 |
| 01:22 ET | 9705 | 89.425 |
| 01:24 ET | 7731 | 89.49 |
| 01:26 ET | 12749 | 89.41 |
| 01:27 ET | 12396 | 89.405 |
| 01:29 ET | 13145 | 89.4 |
| 01:31 ET | 17924 | 89.42 |
| 01:33 ET | 15512 | 89.365 |
| 01:36 ET | 7134 | 89.27 |
| 01:38 ET | 8570 | 89.28 |
| 01:40 ET | 6164 | 89.2 |
| 01:42 ET | 8653 | 89.19 |
| 01:44 ET | 12333 | 89.16 |
| 01:45 ET | 6602 | 89.18 |
| 01:47 ET | 13366 | 89.097 |
| 01:49 ET | 14519 | 89.04 |
| 01:51 ET | 19445 | 89.115 |
| 01:54 ET | 21952 | 89.09 |
| 01:56 ET | 11990 | 89.12 |
| 01:58 ET | 9808 | 89.075 |
| 02:00 ET | 8491 | 89.1 |
| 02:02 ET | 8693 | 89.08 |
| 02:03 ET | 52984 | 89.065 |
| 02:05 ET | 28917 | 88.92 |
| 02:07 ET | 7849 | 88.935 |
| 02:09 ET | 8779 | 88.91 |
| 02:12 ET | 11739 | 88.855 |
| 02:14 ET | 17925 | 88.84 |
| 02:16 ET | 32556 | 88.75 |
| 02:18 ET | 12867 | 88.8 |
| 02:20 ET | 14140 | 88.795 |
| 02:21 ET | 7642 | 88.74 |
| 02:23 ET | 19421 | 88.625 |
| 02:25 ET | 20093 | 88.61 |
| 02:27 ET | 12119 | 88.61 |
| 02:30 ET | 18224 | 88.5875 |
| 02:32 ET | 15577 | 88.59 |
| 02:34 ET | 14927 | 88.71 |
| 02:36 ET | 8717 | 88.67 |
| 02:38 ET | 13838 | 88.68 |
| 02:39 ET | 15113 | 88.735 |
| 02:41 ET | 16173 | 88.885 |
| 02:43 ET | 21933 | 88.98 |
| 02:45 ET | 3015 | 88.94 |
| 03:14 ET | 700 | 88.6 |
| 03:15 ET | 28147 | 88.53 |
| 03:17 ET | 32213 | 88.51 |
| 03:19 ET | 24800 | 88.505 |
| 03:21 ET | 24782 | 88.5 |
| 03:24 ET | 20711 | 88.45 |
| 03:26 ET | 20577 | 88.47 |
| 03:28 ET | 28110 | 88.5 |
| 03:30 ET | 31845 | 88.42 |
| 03:32 ET | 40610 | 88.35 |
| 03:33 ET | 27451 | 88.41 |
| 03:35 ET | 37665 | 88.42 |
| 03:37 ET | 29709 | 88.47 |
| 03:39 ET | 20543 | 88.5 |
| 03:42 ET | 17836 | 88.435 |
| 03:44 ET | 22917 | 88.43 |
| 03:46 ET | 29048 | 88.47 |
| 03:48 ET | 25014 | 88.4634 |
| 03:50 ET | 58747 | 88.48 |
| 03:51 ET | 72877 | 88.32 |
| 03:53 ET | 83363 | 88.31 |
| 03:55 ET | 99636 | 88.2601 |
| 03:57 ET | 175560 | 88.39 |
| 04:00 ET | 1900222 | 88.4 |
Today
DJ Gilead on Pace for Largest Percent Decrease Since February -- Data Talk, from 7 hours ago by Dow Jones
7 hours ago by Dow JonesGilead's Livdelzi (Seladelpar) Demonstrated a Sustained Efficacy and Long-Term Safety Profile in Management of Primary Biliary Cholangitis, from 10 hours ago by Dow Jones
10 hours ago by Dow JonesDJ Gilead Sciences Initiated at Outperform by Wolfe Research, from 15 hours ago by Dow Jones
15 hours ago by Dow Jones
Yesterday
DJ Gilead Sciences Initiated at Buy by Citigroup, from 8:10AM ET on Thursday Nov 14, 2024 by Dow Jones
8:10AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 13, 2024
Gilead Prices $3.5 Billion of Senior Unsecured Notes, from 8:24PM ET on Wednesday Nov 13, 2024 by Dow Jones
8:24PM ET on Wednesday Nov 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Gilead Sciences Inc | 114.8B | 1,052.5x | +1.53% |
Amgen Inc | 159.1B | 36.3x | -0.22% |
Bristol-Myers Squibb Co | 118.6B | -15.6x | +4.90% |
Haleon PLC | 41.6B | 17.6x | --- |
GSK plc | 71.3B | 21.6x | +6.39% |
Sanofi SA | 126.5B | 25.3x | +4.55% |
Company Information
Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. It is focused on the discovery, development and commercialization of medicines in areas of unmet medical need. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, Truvada, Truvada for PrEP, Tybost, Veklury, Vemlidy, Viread, Vosevi, Yescarta and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, and Domvanalimab and zimberelimab, and seladelpar. Seladelpar shall be used for the treatment of primary biliary cholangitis (PBC), including pruritus. The Company operates in more than 35 countries.
Contact Information
- Headquarters
- 333 LAKESIDE DRFOSTER CITY, CA, United States 94404
- Phone
- 650-574-3000
- Fax
- 650-578-9264
Executives
- Chairman of the Board, Chief Executive Officer
- Daniel O'Day
- Chief Financial Officer
- Andrew Dickinson
- Executive Vice President - Corporate Affairs, General Counsel
- Deborah Telman
- Chief Commercial Officer
- Johanna Mercier
- Chief Medical Officer
- Merdad Parsey
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $114.8B |
|---|---|
Revenue (TTM) | $28.3B |
Shares Outstanding | 1.2B |
Dividend Yield | 3.48% |
Annual Dividend Rate | 3.0800 USD |
Ex-Dividend Date | 12-13-24 |
Pay Date | 12-30-24 |
Beta | 0.19 |
EPS | $0.08 |
Book Value | $18.33 |
P/E Ratio | 1,052.5x |
Price/Sales (TTM) | 4.1 |
Price/Cash Flow (TTM) | 39.9x |
Operating Margin | 2.90% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
